CAS: 1188227-29-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 7-BroMo-2-chlorobenzothiazole REF: IN-DA008WWYCAS: 1188227-29-3 | 98% | To inquire | Tue 04 Mar 25 |
 | 7-Bromo-2-chlorobenzo[d]thiazole REF: 54-OR76584CAS: 1188227-29-3 | 0.95 | 261.00 €~3,575.00 € | Mon 03 Mar 25 |
 | 7-Bromo-2-chlorobenzo[d]thiazole REF: 10-F529785CAS: 1188227-29-3 | 95.0% | 78.00 €~1,819.00 € | Wed 05 Mar 25 |
 | 7-Bromo-2-chlorobenzothiazole REF: 3D-NXB22729CAS: 1188227-29-3 | Min. 95% | - - - | Discontinued product |
7-BroMo-2-chlorobenzothiazole
CAS:1188227-29-3
Formula:
C7H3BrClNS
Purity:
98%
Color and Shape:
Solid
Molecular weight:
248.5274
Ref: IN-DA008WWY
| 1g | 181.00 € | ||
| 5g | 567.00 € | ||
| 10g | To inquire | ||
| 25g | To inquire | ||
| 100mg | 75.00 € | ||
| 250mg | 111.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
![7-Bromo-2-chlorobenzo[d]thiazole](https://static.cymitquimica.com/products/54/thumb/OR76584.jpg)
Ref: 54-OR76584
| 1g | 261.00 € | ||
| 5g | 1,068.00 € | ||
| 10g | 1,486.00 € | ||
| 25g | 3,575.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
![7-Bromo-2-chlorobenzo[d]thiazole](https://static.cymitquimica.com/products/10/thumb/F529785.jpg)
7-Bromo-2-chlorobenzo[d]thiazole
CAS:1188227-29-3
Purity:
95.0%
Color and Shape:
Liquid, No data available.
Molecular weight:
248.52000427246094
Ref: 10-F529785
| 1g | 139.00 € | ||
| 5g | 408.00 € | ||
| 10g | 780.00 € | ||
| 25g | 1,819.00 € | ||
| 250mg | 78.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
7-Bromo-2-chlorobenzothiazole
CAS:1188227-29-3
Please enquire for more information about 7-Bromo-2-chlorobenzothiazole including the price, delivery time and more detailed …
Formula:
C7H3BrClNS
Purity:
Min. 95%
Molecular weight:
248.53 g/mol
Ref: 3D-NXB22729
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
